Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
1.39
Dollar change
+0.26
Percentage change
23.01
%
IndexRUT P/E- EPS (ttm)-1.98 Insider Own26.22% Shs Outstand59.51M Perf Week14.88%
Market Cap91.85M Forward P/E- EPS next Y-1.72 Insider Trans-0.04% Shs Float48.75M Perf Month42.55%
Income-123.83M PEG- EPS next Q-0.48 Inst Own74.29% Short Float / Ratio6.34% / 5.26 Perf Quarter-72.53%
Sales3.03M P/S30.31 EPS this Y17.50% Inst Trans1.06% Short Interest3.09M Perf Half Y-64.63%
Book/sh3.52 P/B0.40 EPS next Y11.54% ROA-31.58% Target Price8.25 Perf Year-73.92%
Cash/sh4.40 P/C0.32 EPS next 5Y- ROE-45.81% 52W Range0.86 - 7.35 Perf YTD-64.63%
Dividend- P/FCF- EPS past 5Y-31.99% ROI-40.88% 52W High-81.09% Beta2.49
Dividend %- Quick Ratio9.07 Sales past 5Y-25.00% Gross Margin-74.62% 52W Low61.63% ATR0.17
Employees150 Current Ratio9.07 Sales Q/Q- Oper. Margin-4465.47% RSI (14)49.67 Volatility13.59% 13.37%
OptionableYes Debt/Eq0.34 EPS Q/Q19.35% Profit Margin-4092.23% Rel Volume5.28 Prev Close1.13
ShortableYes LT Debt/Eq0.31 EarningsNov 09 AMC Payout- Avg Volume588.29K Price1.39
Recom2.00 SMA2019.49% SMA50-31.06% SMA200-64.98% Volume3,103,472 Change23.01%
Date Action Analyst Rating Change Price Target Change
Oct-19-23Downgrade TD Cowen Outperform → Market Perform
Nov-08-22Initiated Canaccord Genuity Buy $9
Dec-14-21Downgrade William Blair Outperform → Mkt Perform
Jun-08-21Initiated JMP Securities Mkt Outperform $40
Feb-24-21Initiated William Blair Outperform
Feb-18-21Initiated Needham Buy $50
Jul-07-20Initiated Wedbush Outperform $31
Jul-07-20Initiated JP Morgan Overweight $28
Jul-07-20Initiated Jefferies Buy $38
Jul-07-20Initiated Cowen Outperform
Nov-29-23 08:41AM
06:59AM
Nov-09-23 04:15PM
Oct-26-23 06:59AM
Oct-18-23 06:59AM
07:30AM Loading…
Sep-19-23 07:30AM
Aug-03-23 08:49AM
07:30AM
Aug-02-23 07:05PM
04:15PM
May-31-23 07:30AM
May-10-23 06:05PM
04:15PM
May-09-23 04:15PM
Apr-11-23 07:30AM
09:40AM Loading…
Apr-10-23 09:40AM
Apr-05-23 07:30AM
Mar-24-23 03:02PM
Mar-23-23 10:43AM
07:29AM
07:00AM
Mar-21-23 04:15PM
Feb-27-23 07:30AM
Feb-24-23 07:18AM
Feb-23-23 04:28PM
Jan-03-23 04:30PM
Dec-05-22 09:55AM
Nov-17-22 09:55AM
Nov-03-22 04:15PM
Nov-01-22 08:07AM
07:30AM Loading…
Sep-22-22 07:30AM
Sep-20-22 07:30AM
Sep-17-22 08:12AM
Aug-04-22 05:45PM
04:15PM
Aug-02-22 04:15PM
Jul-18-22 07:30AM
Jul-11-22 09:55AM
Jun-21-22 08:30AM
Jun-02-22 07:30AM
May-25-22 06:37AM
May-05-22 07:05PM
04:15PM
Apr-05-22 07:30AM
Mar-25-22 12:00PM
10:00AM
Mar-02-22 07:30AM
Feb-24-22 04:20PM
Feb-10-22 07:30AM
Jan-05-22 07:30AM
Dec-28-21 07:37PM
Dec-19-21 09:37PM
Dec-16-21 11:02PM
06:38PM
07:01AM
Dec-14-21 06:30AM
12:38AM
Nov-10-21 04:20PM
Oct-22-21 07:30AM
Oct-21-21 04:05PM
Oct-15-21 07:30AM
Sep-30-21 11:12AM
Sep-17-21 08:34AM
Aug-11-21 04:20PM
Aug-03-21 07:30AM
Jul-14-21 07:30AM
Jul-08-21 07:30AM
Jun-19-21 05:55AM
Jun-09-21 07:30AM
May-27-21 07:30AM
May-12-21 04:20PM
Apr-27-21 04:35PM
Apr-08-21 07:30AM
Mar-21-21 05:20AM
Mar-18-21 08:00AM
Mar-01-21 08:53AM
Feb-18-21 10:02AM
07:30AM
Jan-13-21 11:29PM
Jan-11-21 05:43PM
Jan-06-21 09:24PM
Jan-05-21 08:44AM
06:30AM
Jan-04-21 06:30AM
Dec-13-20 03:52AM
Dec-02-20 11:34PM
Nov-10-20 06:30AM
Oct-31-20 08:00AM
Oct-05-20 06:30AM
Sep-24-20 06:30AM
Sep-14-20 10:59AM
Aug-11-20 06:30AM
Aug-05-20 06:30AM
Jul-22-20 07:00AM
Jun-16-20 04:02PM
Jun-12-20 12:31PM
06:24AM
Jun-11-20 09:52PM
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Paone AntoinetteCHIEF OPERATING OFFICERAug 23Sale4.933,11615,3622,914Aug 25 04:35 PM
Samayoa PhillipCHIEF STRATEGY OFFICERJul 03Sale5.293,11616,484101,428Jul 05 04:35 PM
Paone AntoinetteCHIEF OPERATING OFFICERApr 25Sale4.612,91413,4340Apr 26 04:16 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 26Sale5.562,69514,9840Jan 27 04:22 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 10Sale4.571,8658,5230Jan 11 04:25 PM
Samayoa PhillipCHIEF STRATEGY OFFICERJan 09Sale5.111,8659,53095,819Jan 10 04:57 PM